Bacterial production of ciprofloxacin and potential usage as a radiotracer Journal Article


Authors: Karatay, K. B.; Gungor, N. D.; Colak, B.; Muftuler, F. Z. B.; Aras, O.
Article Title: Bacterial production of ciprofloxacin and potential usage as a radiotracer
Abstract: Infectious diseases caused by bacteria that have become resistant to antibiotics have increased in prevalence, necessitating new methods for their diagnosis and treatment. The aim of this study was to compare the efficacy of synthetic ciprofloxacin to that of organic ciprofloxacin produced by cave microorganisms, as well as to evaluate the feasibility of using organic ciprofloxacin radiolabeled with technetium-99m as an imaging agent. Organic ciprofloxacin produced by cave bacteria isolated from sediment taken from the dark zone of Antalya's "Yark Sinkhole,"(Turkey's 14th deepest cave), was purified using high-performance liquid chromatography. Purified organic ciprofloxacin and standard ciprofloxacin were radiolabeled with technetium-99m (99mTc), and their uptake by pathogenic microorganisms as well as potential as an imaging agent were examined. According to thin-layer radiochromatography, radiolabeling efficiencies were 98.99 ± 0.34 (n = 7) and 91.25 ± 1.84 (n = 7) for radiolabeled organic ciprofloxacin and standard ciprofloxacin respectively. The binding efficiency of radiolabeled organic ciprofloxacin at the 240th minute was higher compared with radiolabeled standard ciprofloxacin, especially with P.aeruginosa, MRSA, VRE and E.coli. The results demonstrate that radiolabeling with 99mTc does not alter the biological behavior of organic ciprofloxacin, and radiolabeled organic ciprofloxacin has potential as an imaging agent for the detection of bacterial infection. The original value of the study is the monitoring of the antibiofilm effects of untouched cave-derived organic antibiotics by radiolabeling with a radionuclide. © 2023 Karatay et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Keywords: antibiotic agent; drug efficacy; nonhuman; technetium 99m; radiopharmaceuticals; polymerase chain reaction; quality control; metabolism; prevalence; bacterial strain; antiinfective agent; antibiotic resistance; chemistry; anti-bacterial agents; escherichia coli; ciprofloxacin; radiopharmaceutical agent; scintiscanning; high performance liquid chromatography; tracer; radioisotope; staphylococcus aureus; methicillin resistant staphylococcus aureus; vancomycin resistant enterococcus; bacterial dna; bacterial infection; dna extraction; thin layer chromatography; candida albicans; radionuclide imaging; bacterium; bacterium isolation; linear regression analysis; colony forming unit; pseudomonas aeruginosa; antimicrobial activity; electrospray; minimum inhibitory concentration; liquid chromatography-mass spectrometry; technetium; radiolabeling; article; cave; antibiofilm activity; micrococcus luteus; radiochromatography; sediment
Journal Title: PLoS ONE
Volume: 18
Issue: 11
ISSN: 1932-6203
Publisher: Public Library of Science  
Date Published: 2023-11-09
Start Page: e0291342
Language: English
DOI: 10.1371/journal.pone.0291342
PUBMED: 37943851
PROVIDER: scopus
PMCID: PMC10635501
DOI/URL:
Notes: Article -- MSK Cancer Center Support Grant (P30 CA008748) acknowledged in PubMed and PDF -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Omer Aras
    75 Aras